2000
DOI: 10.1016/s0049-3848(00)00270-x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Acetyl Salicylic Acid Therapy on an Experimental Thrombosis Induced by Laser Beam

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2003
2003
2010
2010

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…The first experimental model showed paradoxical or secondary thromboembolism after the administration of substantial [6][7][8][9][10][11][12][13][14][15] or ultra low 16,17 doses of antithrombotic agents (rebound effect). The second model showed the effect of substantial 18 or ultra low [19][20][21][22][23] doses of aspirin in prophylaxis or reduction of hemorrhagic risks (reducing the bleeding time or the antithrombotic effect), neutralising the side effect of aspirin previously administration in high doses (identity principle or curative rebound effect).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The first experimental model showed paradoxical or secondary thromboembolism after the administration of substantial [6][7][8][9][10][11][12][13][14][15] or ultra low 16,17 doses of antithrombotic agents (rebound effect). The second model showed the effect of substantial 18 or ultra low [19][20][21][22][23] doses of aspirin in prophylaxis or reduction of hemorrhagic risks (reducing the bleeding time or the antithrombotic effect), neutralising the side effect of aspirin previously administration in high doses (identity principle or curative rebound effect).…”
Section: Discussionmentioning
confidence: 99%
“…Experimental studies, in vitro and in vivo, show that after the interruption or discontinuation of ASA or other drugs for prophylaxis of thromboembolism, the organism reacts by a secondary action or vital reaction that stimulates the COX-1 production and the blood platelet activity to values much higher than baseline, increasing the development of thrombus and the probability of a embolic event [acute myocardial infarction (AMI), cerebral vascular accident (CVA), etc] in susceptible individuals, both in substantial, [6][7][8][9][10][11][12][13][14][15] and infinitesimal doses. 16,17 Other experiments showed the effect of substantial 18 or ultra low [19][20][21][22][23] doses of aspirin in prophylaxis or reduction of haemorrhagic risks (reducing the bleeding time or the anti-thrombotic effect), neutralising the side effect of previously administered aspirin.…”
Section: Similitude and Aspirinmentioning
confidence: 99%
“…Subsequently, this group 53 also demonstrated a potent antithromboembolic effect of potentized acetyl salicyclic acid in similarly induced experimental thrombosis. Researchers in Germany have observed an inhibitory effect of ultradiluted dichlorophenol on the bacterium Vibrio fischeri.…”
Section: In Vivo Laboratory Experiments and A Few Other Hypotheses Onmentioning
confidence: 95%
“…We previously demonstrated a prothrombotic activity of aspirin 7 days after a single-dose administration (100 mg/kg) as evidenced by an increase in the number of emboli and the duration of embolization [11] . We suggested that this effect may explain thromboembolic complications observed in patients after they had stopped aspirin therapy.…”
Section: Discussionmentioning
confidence: 97%
“…We have previously demonstrated that aspirin could exhibit late thrombotic properties 8-10 days after administration. This phenomenon might explain the thromboembolic complications observed in some patients [10,11] . We have also shown that aspirin at ultra low dose (ULDA) has prothrombotic activity [12] .…”
Section: Introductionmentioning
confidence: 90%